Zobrazeno 1 - 10
of 42
pro vyhledávání: '"Srividhya Venkataraman"'
Autor:
Reza Salahlou, Safar Farajnia, Nasrin Bargahi, Nasim Bakhtiyari, Faranak Elmi, Mehdi Shahgolzari, Steven Fiering, Srividhya Venkataraman
Publikováno v:
BMC Infectious Diseases, Vol 24, Iss 1, Pp 1-25 (2024)
Abstract Background Human polyomaviruses contribute to human oncogenesis through persistent infections, but currently there is no effective preventive measure against the malignancies caused by this virus. Therefore, the development of a safe and eff
Externí odkaz:
https://doaj.org/article/9ec23e7fb9014ba0b9d970e9a1f29dc3
Publikováno v:
Frontiers in Plant Science, Vol 14 (2023)
Plants have been explored as a platform to produce pharmaceutical proteins for over 20 years. Important features such as the cost-effectiveness of production, the ease of scaling up to manufacturing capacity, the lack of cold chain requirements and t
Externí odkaz:
https://doaj.org/article/38025a904251489dac572683413d133d
Autor:
Goabaone Gaobotse, Srividhya Venkataraman, Phenyo D. Brown, Kabo Masisi, Tebogo E. Kwape, David O. Nkwe, Gaolathe Rantong, Abdullah Makhzoum
Publikováno v:
Frontiers in Pharmacology, Vol 14 (2023)
Cancer is the third leading cause of premature death in sub-Saharan Africa. Cervical cancer has the highest number of incidences in sub-Saharan Africa due to high HIV prevalence (70% of global cases) in African countries which is linked to increasing
Externí odkaz:
https://doaj.org/article/f38f74ee09e04177ae793a301e4b98e7
Publikováno v:
Vaccines, Vol 11, Iss 8, p 1278 (2023)
Plant virus nanoparticles (PVNPs) have garnered considerable interest as a promising nanotechnology approach to combat cancer. Owing to their biocompatibility, stability, and adjustable surface functionality, PVNPs hold tremendous potential for both
Externí odkaz:
https://doaj.org/article/edbe1c179bf54d3f9d3e2341c3671066
Publikováno v:
Frontiers in Bioengineering and Biotechnology, Vol 9 (2021)
Plant virus nanoparticles (VNPs) are inexpensive to produce, safe, biodegradable and efficacious as treatments. The applications of r plant virus nanoparticles range from epitope carriers for vaccines to agents in cancer immunotherapy. Both VNPs and
Externí odkaz:
https://doaj.org/article/f4446493b598493eb4f233aafa248707
Autor:
Goabaone Gaobotse, Srividhya Venkataraman, Kamogelo M. Mmereke, Khaled Moustafa, Kathleen Hefferon, Abdullah Makhzoum
Publikováno v:
Vaccines, Vol 10, Iss 11, p 1861 (2022)
The development of vaccines from plants has been going on for over two decades now. Vaccine production in plants requires time and a lot of effort. Despite global efforts in plant-made vaccine development, there are still challenges that hinder the r
Externí odkaz:
https://doaj.org/article/e82e4f9fe9e04b28ad187e41ed847e0b
Autor:
Srividhya Venkataraman
Publikováno v:
Vaccines, Vol 10, Iss 11, p 1805 (2022)
The current century has witnessed infections of pandemic proportions caused by Coronaviruses (CoV) including severe acute respiratory syndrome-related CoV (SARS-CoV), Middle East respiratory syndrome-related CoV (MERS-CoV) and the recently identified
Externí odkaz:
https://doaj.org/article/256dd277f7da4c7d979e22224910e6a2
Publikováno v:
Viruses, Vol 13, Iss 9, p 1697 (2021)
Plant-based nanotechnology programs using virus-like particles (VLPs) and virus nanoparticles (VNPs) are emerging platforms that are increasingly used for a variety of applications in biotechnology and medicine. Tobacco mosaic virus (TMV) and potato
Externí odkaz:
https://doaj.org/article/601148b99ce0418aa205405c1968e36a
Publikováno v:
Vaccines, Vol 9, Iss 8, p 830 (2021)
Naturally occurring viral nanomaterials have gained popularity owing to their biocompatible and biodegradable nature. Plant virus nanoparticles (VNPs) can be used as nanocarriers for a number of biomedical applications. Plant VNPs are inexpensive to
Externí odkaz:
https://doaj.org/article/41fdf532ce9b44f1bf8d3930eeed859b
Publikováno v:
Vaccines, Vol 9, Iss 7, p 761 (2021)
Molecular pharming or the technology of application of plants and plant cell culture to manufacture high-value recombinant proteins has progressed a long way over the last three decades. Whether generated in transgenic plants by stable expression or
Externí odkaz:
https://doaj.org/article/288e4e0f7d3d4bcbb447e341262e5275